Denmark· DK-28105074412
Gliclazid "Krka d.d."
A gliclazide product containing gliclazid, registered in Denmark by KRKA d.d. Novo mesto. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Gliclazide is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BB09 (gliclazide), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Gliclazide · ATC A10BB09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of gliclazide costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.11 in France to $0.61 in Switzerland — a ×5.5 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gliclazide · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.61
- IT Italy$0.26
- FR France$0.11
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- GLICLAZID
- Manufacturer
- KRKA d.d. Novo mesto
- Country
- Denmark (DK)
- ATC code
- A10BB09
- ATC class
- Gliclazide
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105074412
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for gliclazide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gliclazide · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under A10BB09
Gliclazide, as other registers publish it.
- CanadaAG-GLICLAZIDE MRANGITA PHARMA INC.
- CanadaAG-GLICLAZIDE MRANGITA PHARMA INC.
- CanadaAPO-GLICLAZIDEAPOTEX INC
- CanadaAPO-GLICLAZIDE MRAPOTEX INC
- CanadaAPO-GLICLAZIDE MRAPOTEX INC
- United KingdomBilxona 30mg modified-release tabletsAccord-UK Ltd
- United KingdomBilxona 60mg modified-release tabletsActavis UK Ltd
- United KingdomBilxona 60mg modified-release tabletsAccord-UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b88acb66-09d7-4d35-a417-fe130fd7523e GET /v1/drugs/b88acb66-09d7-4d35-a417-fe130fd7523e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter med modificeret udløsning",
"source": "dkma",
"strength": "30 mg",
"auth_role": "RMS",
"dk_drugid": "28105074412",
"substance": "GLICLAZID",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "41416"
}See everything about gliclazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.